Chapter 7. mRNA Therapeutics Contract Development and Manufacturing (CDMO) Market Regional Analysis
7.1. mRNA Therapeutics Contract Development and Manufacturing (CDMO) Regional market share analysis, 2022 & 2030
7.2. North America
7.2.1. North America Market estimates and forecast, 2020 - 2030
7.2.2. U.S.
7.2.2.1. U.S. Market estimates and forecast, 2020 - 2030
7.2.3. Canada
7.2.3.1. Canada Market estimates and forecast, 2020 - 2030
7.3. Europe
7.3.1. Europe Market estimates and forecast, 2020 - 2030
7.3.2. UK
7.3.2.1. UK Market estimates and forecast, 2020 - 2030
7.3.3. Germany
7.3.3.1. Germany Market estimates and forecast, 2020 - 2030
7.3.4. France
7.3.4.1. France Market estimates and forecast, 2020 - 2030
7.3.5. Italy
7.3.5.1. Italy Market estimates and forecast, 2020 - 2030
7.3.6. Spain
7.3.6.1. Spain Market estimates and forecast, 2020 - 2030
7.3.7. Denmark
7.3.7.1. Denmark Market estimates and forecast, 2020 - 2030
7.3.8. Sweden
7.3.8.1. Sweden Market estimates and forecast, 2020 - 2030
7.3.9. Norway
7.3.9.1. Norway Market estimates and forecast, 2020 - 2030
7.4. Asia Pacific
7.4.1. Asia Pacific Market estimates and forecast, 2020 - 2030
7.4.2. Japan
7.4.2.1. Japan Market estimates and forecast, 2020 - 2030
7.4.3. China
7.4.3.1. China Market estimates and forecast, 2020 - 2030
7.4.4. India
7.4.4.1. India Market estimates and forecast, 2020 - 2030
7.4.5. South Korea
7.4.5.1. South Korea Market estimates and forecast, 2020 - 2030
7.4.6. Australia
7.4.6.1. Australia Market estimates and forecast, 2020 - 2030
7.4.7. Thailand
7.4.7.1. Thailand Market estimates and forecast, 2020 - 2030
7.4.8. South Korea
7.4.8.1. South Korea Market estimates and forecast, 2020 - 2030
7.5. Latin America
7.5.1. Latin America Market estimates and forecast, 2020 - 2030
7.5.2. Brazil
7.5.2.1. Brazil Market estimates and forecast, 2020 - 2030
7.5.3. Mexico
7.5.3.1. Mexico Market estimates and forecast, 2020 - 2030
7.5.4. Argentina
7.5.4.1. Argentina Market estimates and forecast, 2020 - 2030
7.5.5. Colombia
7.5.5.1. Colombia Market estimates and forecast, 2020 - 2030
7.5.6. Chile
7.5.6.1. Chile Market estimates and forecast, 2020 - 2030
7.6. MEA
7.6.1. MEA Market estimates and forecast, 2020 - 2030
7.6.2. South Africa
7.6.2.1. South Africa Market estimates and forecast, 2020 - 2030
7.6.3. Saudi Arabia
7.6.3.1. Saudi Arabia Market estimates and forecast, 2020 - 2030
7.6.4. UAE
7.6.4.1. UAE Market estimates and forecast, 2020 - 2030
7.6.5. Kuwait
7.6.5.1. Kuwait Market estimates and forecast, 2020 - 2030
List of Tables
Table 1: List of secondary sources
Table 2: List of abbreviations
Table 3: Global mRNA therapeutics contract development and manufacturing (CDMO) market, by application, 2020-2030 (USD Million)
Table 4: Global mRNA therapeutics contract development and manufacturing (CDMO) market, by indication, 2020-2030 (USD Million)
Table 5: Global mRNA therapeutics contract development and manufacturing (CDMO) market, by end user, 2020-2030 (USD Million)
Table 6: Global mRNA therapeutics contract development and manufacturing (CDMO) market, by region, 2020-2030 (USD Million)
Table 7: North America mRNA therapeutics contract development and manufacturing (CDMO) market, by country, 2020-2030 (USD Million)
Table 8: North America mRNA therapeutics contract development and manufacturing (CDMO) market, by application, 2020-2030 (USD Million)
Table 9: North America mRNA therapeutics contract development and manufacturing (CDMO) market, by indication, 2020-2030 (USD Million)
Table 10: North America mRNA therapeutics contract development and manufacturing (CDMO) market, by end user, 2020-2030 (USD Million)
Table 11: U.S. mRNA therapeutics contract development and manufacturing (CDMO) market, by application, 2020-2030 (USD Million)
Table 12: U.S. mRNA therapeutics contract development and manufacturing (CDMO) market, by indication, 2020-2030 (USD Million)
Table 13: U.S. mRNA therapeutics contract development and manufacturing (CDMO) market, by end user, 2020-2030 (USD Million)
Table 14: Canada mRNA therapeutics contract development and manufacturing (CDMO) market, by application, 2020-2030, (USD million
Table 15: Canada mRNA therapeutics contract development and manufacturing (CDMO) market, by indication, 2020-2030 (USD Million)
Table 16: Canada mRNA therapeutics contract development and manufacturing (CDMO) market, by end user, 2020-2030 (USD Million)
Table 17: Europe mRNA therapeutics contract development and manufacturing (CDMO) market, by country, 2020-2030 (USD Million)
Table 18: Europe mRNA therapeutics contract development and manufacturing (CDMO) market, by application, 2020-2030 (USD Million)
Table 19: Europe mRNA therapeutics contract development and manufacturing (CDMO) market, by indication, 2020-2030 (USD Million)
Table 20: Europe mRNA therapeutics contract development and manufacturing (CDMO) market, by end user, 2020-2030 (USD Million)
Table 21: Germany mRNA therapeutics contract development and manufacturing (CDMO) market, by application, 2020-2030 (USD Million)
Table 22: Germany mRNA therapeutics contract development and manufacturing (CDMO) market, by indication, 2020-2030 (USD Million)
Table 23: Germany mRNA therapeutics contract development and manufacturing (CDMO) market, by end user, 2020-2030 (USD Million)
Table 24: UK mRNA therapeutics contract development and manufacturing (CDMO) market, by application, 2020-2030 (USD Million)
Table 25: UK mRNA therapeutics contract development and manufacturing (CDMO) market, by indication, 2020-2030 (USD Million)
Table 26: UK mRNA therapeutics contract development and manufacturing (CDMO) market, by end user, 2020-2030 (USD Million)
Table 27: France mRNA therapeutics contract development and manufacturing (CDMO) market, by application, 2020-2030 (USD Million)
Table 28: France mRNA therapeutics contract development and manufacturing (CDMO) market, by indication, 2020-2030 (USD Million)
Table 29: France mRNA therapeutics contract development and manufacturing (CDMO) market, by end user, 2020-2030 (USD Million)
Table 30: France mRNA therapeutics contract development and manufacturing (CDMO) market, by application, 2020-2030 (USD Million)
Table 31: Italy mRNA therapeutics contract development and manufacturing (CDMO) market, by indication, 2020-2030 (USD Million)
Table 32: Italy mRNA therapeutics contract development and manufacturing (CDMO) market, by end user, 2020-2030 (USD Million)
Table 33: Spain mRNA therapeutics contract development and manufacturing (CDMO) market, by application, 2020-2030 (USD Million)
Table 34: Spain mRNA therapeutics contract development and manufacturing (CDMO) market, by indication, 2020-2030 (USD Million)
Table 35: Spain mRNA therapeutics contract development and manufacturing (CDMO) market, by end user, 2020-2030 (USD Million)
Table 36: Denmark mRNA therapeutics contract development and manufacturing (CDMO) market, by application, 2020-2030 (USD Million)
Table 37: Denmark mRNA therapeutics contract development and manufacturing (CDMO) market, by indication, 2020-2030 (USD Million)
Table 38: Denmark mRNA therapeutics contract development and manufacturing (CDMO) market, by end user, 2020-2030 (USD Million)
Table 39: Sweden mRNA therapeutics contract development and manufacturing (CDMO) market, by application, 2020-2030 (USD Million)
Table 40: Sweden mRNA therapeutics contract development and manufacturing (CDMO) market, by indication, 2020-2030 (USD Million)
Table 41: Sweden mRNA therapeutics contract development and manufacturing (CDMO) market, by end user, 2020-2030 (USD Million)
Table 42: Norway mRNA therapeutics contract development and manufacturing (CDMO) market, by application, 2020-2030 (USD Million)
Table 43: Norway mRNA therapeutics contract development and manufacturing (CDMO) market, by indication, 2020-2030 (USD Million)
Table 44: Norway mRNA therapeutics contract development and manufacturing (CDMO) market, by end user, 2020-2030 (USD Million)
Table 45: Asia Pacific mRNA therapeutics contract development and manufacturing (CDMO) market, by country, 2020-2030 (USD Million)
Table 46: Asia Pacific mRNA therapeutics contract development and manufacturing (CDMO) market, by application, 2020-2030 (USD Million)
Table 47: Asia Pacific mRNA therapeutics contract development and manufacturing (CDMO) market, by indication, 2020-2030 (USD Million)
Table 48: Asia Pacific mRNA therapeutics contract development and manufacturing (CDMO) market, by end user, 2020-2030 (USD Million)
Table 49: Japan mRNA therapeutics contract development and manufacturing (CDMO) market, by application, 2020-2030 (USD Million)
Table 50: Japan mRNA therapeutics contract development and manufacturing (CDMO) market, by indication, 2020-2030 (USD Million)
Table 51: Japan mRNA therapeutics contract development and manufacturing (CDMO) market, by end user, 2020-2030 (USD Million)
Table 52: China mRNA therapeutics contract development and manufacturing (CDMO) market, by application, 2020-2030 (USD Million)
Table 53: China mRNA therapeutics contract development and manufacturing (CDMO) market, by indication, 2020-2030 (USD Million)
Table 54: China mRNA therapeutics contract development and manufacturing (CDMO) market, by end user, 2020-2030 (USD Million)
Table 55: India mRNA therapeutics contract development and manufacturing (CDMO) market, by application, 2020-2030 (USD Million)
Table 56: India mRNA therapeutics contract development and manufacturing (CDMO) market, by indication, 2020-2030 (USD Million)
Table 57: India mRNA therapeutics contract development and manufacturing (CDMO) market, by end user, 2020-2030 (USD Million)
Table 58: Australia mRNA therapeutics contract development and manufacturing (CDMO) market, by application, 2020-2030 (USD Million)
Table 59: Australia mRNA therapeutics contract development and manufacturing (CDMO) market, by indication, 2020-2030 (USD Million)
Table 60: Australia mRNA therapeutics contract development and manufacturing (CDMO) market, by end user, 2020-2030 (USD Million)
Table 61: South Korea mRNA therapeutics contract development and manufacturing (CDMO) market, by application, 2020-2030 (USD Million)
Table 62: South Korea mRNA therapeutics contract development and manufacturing (CDMO) market, by indication, 2020-2030 (USD Million)
Table 63: South Korea mRNA therapeutics contract development and manufacturing (CDMO) market, by end user, 2020-2030 (USD Million)
Table 64: Thailand mRNA therapeutics contract development and manufacturing (CDMO) market, by application, 2020-2030 (USD Million)
Table 65: Thailand mRNA therapeutics contract development and manufacturing (CDMO) market, by indication, 2020-2030 (USD Million)
Table 66: Thailand mRNA therapeutics contract development and manufacturing (CDMO) market, by end user, 2020-2030 (USD Million)
Table 67: Latin America mRNA therapeutics contract development and manufacturing (CDMO) market, by country, 2020-2030 (USD Million)
Table 68: Latin America mRNA therapeutics contract development and manufacturing (CDMO) market, by application, 2020-2030 (USD Million)
Table 69: Latin America mRNA therapeutics contract development and manufacturing (CDMO) market, by indication, 2020-2030 (USD Million)
Table 70: Latin America mRNA therapeutics contract development and manufacturing (CDMO) market, by end user, 2020-2030 (USD Million)
Table 71: Brazil mRNA therapeutics contract development and manufacturing (CDMO) market, by application, 2020-2030 (USD Million)
Table 72: Brazil mRNA therapeutics contract development and manufacturing (CDMO) market, by indication, 2020-2030 (USD Million)
Table 73: Brazil mRNA therapeutics contract development and manufacturing (CDMO) market, by end user, 2020-2030 (USD Million)
Table 74: Mexico mRNA therapeutics contract development and manufacturing (CDMO) market, by application, 2020-2030 (USD Million)
Table 75: Mexico mRNA therapeutics contract development and manufacturing (CDMO) market, by indication, 2020-2030 (USD Million)
Table 76: Mexico mRNA therapeutics contract development and manufacturing (CDMO) market, by end user, 2020-2030 (USD Million)
Table 77: Argentina mRNA therapeutics contract development and manufacturing (CDMO) market, by application, 2020-2030 (USD Million)
Table 78: Argentina mRNA therapeutics contract development and manufacturing (CDMO) market, by indication, 2020-2030 (USD Million)
Table 79: Argentina mRNA therapeutics contract development and manufacturing (CDMO) market, by end user, 2020-2030 (USD Million)
Table 80: Middle East & Africa mRNA therapeutics contract development and manufacturing (CDMO) market, by country, 2020-2030 (USD Million)
Table 81: Middle East & Africa mRNA therapeutics contract development and manufacturing (CDMO) market, by application, 2020-2030 (USD Million)
Table 82: Middle East & Africa mRNA therapeutics contract development and manufacturing (CDMO) market, by indication, 2020-2030 (USD Million)
Table 83: Middle East & Africa mRNA therapeutics contract development and manufacturing (CDMO) market, by end user, 2020-2030 (USD Million)
Table 84: South Africa mRNA therapeutics contract development and manufacturing (CDMO) market, by application, 2020-2030 (USD Million)
Table 85: South Africa mRNA therapeutics contract development and manufacturing (CDMO) market, by indication, 2020-2030 (USD Million)
Table 86: South Africa mRNA therapeutics contract development and manufacturing (CDMO) market, by end user, 2020-2030 (USD Million)
Table 87: Saudi Arabia mRNA therapeutics contract development and manufacturing (CDMO) market, by application, 2020-2030 (USD Million)
Table 88: Saudi Arabia mRNA therapeutics contract development and manufacturing (CDMO) market, by indication, 2020-2030 (USD Million)
Table 89: Saudi Arabia mRNA therapeutics contract development and manufacturing (CDMO) market, by application, 2020-2030 (USD Million)
Table 90: Saudi Arabia mRNA therapeutics contract development and manufacturing (CDMO) market, by end user, 2020-2030 (USD Million)
Table 91: UAE mRNA therapeutics contract development and manufacturing (CDMO) market, by application, 2020-2030 (USD Million)
Table 92: UAE mRNA therapeutics contract development and manufacturing (CDMO) market, by indication, 2020-2030 (USD Million)
Table 93: UAE mRNA therapeutics contract development and manufacturing (CDMO) market, by end user, 2020-2030 (USD Million)
Table 94: Kuwait mRNA therapeutics contract development and manufacturing (CDMO) market, by application, 2020-2030 (USD Million)
Table 95: Kuwait mRNA therapeutics contract development and manufacturing (CDMO) market, by indication, 2020-2030 (USD Million)
Table 96: Kuwait mRNA therapeutics contract development and manufacturing (CDMO) market, by end user, 2020-2030 (USD Million)
List of Figures
Fig. 1: mRNA therapeutics contract development and manufacturing (CDMO) market segmentation
Fig. 2: Market research process
Fig. 3: Data triangulation techniques
Fig. 4: Primary research pattern
Fig. 5: Market research approaches
Fig. 6: Value-chain-based sizing & forecasting
Fig. 7: QFD modeling for market share assessment
Fig. 8: Market formulation & validation
Fig. 9: Market snapshot
Fig. 10: Segment snapshot
Fig. 11: Competitive landscape snapshot
Fig. 12: Parent market outlook
Fig. 13: Related/ancillary market outlook
Fig. 14: mRNA Therapeutics Contract Development and Manufacturing (CDMO) - Industry value chain analysis
Fig. 15: mRNA therapeutics contract development and manufacturing (CDMO) market driver analysis
Fig. 16: mRNA therapeutics contract development and manufacturing (CDMO) market restraint analysis
Fig. 17: mRNA therapeutics contract development and manufacturing (CDMO) market: Porter's analysis
Fig. 18: mRNA therapeutics contract development and manufacturing (CDMO) market: PESTLE analysis
Fig. 19: mRNA therapeutics contract development and manufacturing (CDMO) market: application outlook and key takeaways
Fig. 20: mRNA therapeutics contract development and manufacturing (CDMO) market: application market share analysis, 2022-2030
Fig. 21: Global viral vaccines development market, 2020-2030 (USD Million)
Fig. 22: Global protein replacement therapies market, 2020-2030 (USD Million)
Fig. 23: Global cancer immunotherapies market, 2020-2030 (USD Million)
Fig. 24: mRNA therapeutics contract development and manufacturing (CDMO) market: Indication outlook and key takeaways
Fig. 25: mRNA therapeutics contract development and manufacturing (CDMO) market: Indication market share analysis, 2022-2030
Fig. 26: Global infectious diseases market, 2020-2030 (USD Million)
Fig. 27: Global metabolic & genetic diseases market, 2020-2030 (USD Million)
Fig. 28: Global cardiovascular and cerebrovascular diseases market, 2020-2030 (USD Million)
Fig. 29: mRNA therapeutics contract development and manufacturing (CDMO) market: End-user outlook and key takeaways
Fig. 30: mRNA therapeutics contract development and manufacturing (CDMO) market: End-user market share analysis, 2022-2030
Fig. 31: Global biotech companies market, 2020-2030 (USD Million)
Fig. 32: Global pharmaceutical companies market, 2020-2030 (USD Million)
Fig. 33: Global government & academic research institutes market, 2020-2030 (USD Million)
Fig. 34: Regional marketplace: Key takeaways
Fig. 35: Regional marketplace: Key takeaways
Fig. 36: North America mRNA therapeutics contract development and manufacturing (CDMO) market estimates and forecast, 2020-2030 (USD Million)
Fig. 37: U.S. key country dynamics
Fig. 38: U.S. mRNA therapeutics contract development and manufacturing (CDMO) market estimates and forecast, 2020-2030 (USD Million)
Fig. 39: Canada key country dynamics
Fig. 40: Canada mRNA therapeutics contract development and manufacturing (CDMO) market, 2020-2030 (USD Million)
Fig. 41: Europe mRNA therapeutics contract development and manufacturing (CDMO) market estimates and forecast, 2020-2030 (USD Million)
Fig. 42: Germany key country dynamics
Fig. 43: Germany mRNA therapeutics contract development and manufacturing (CDMO) market estimates and forecast, 2020-2030 (USD Million)
Fig. 44: UK key country dynamics
Fig. 45: UK mRNA therapeutics contract development and manufacturing (CDMO) market estimates and forecast, 2020-2030 (USD Million)
Fig. 46: France key country dynamics
Fig. 47: France mRNA therapeutics contract development and manufacturing (CDMO) market estimates and forecast, 2020-2030 (USD Million)
Fig. 48: Italy key country dynamics
Fig. 49: Italy mRNA therapeutics contract development and manufacturing (CDMO) market estimates and forecast, 2020-2030 (USD Million)
Fig. 50: Spain key country dynamics
Fig. 51: Spain mRNA therapeutics contract development and manufacturing (CDMO) market estimates and forecast, 2020-2030 (USD Million)
Fig. 52: Denmark key country dynamics
Fig. 53: Denmark mRNA therapeutics contract development and manufacturing (CDMO) market estimates and forecast, 2020-2030 (USD Million)
Fig. 54: Sweden key country dynamics
Fig. 55: Sweden mRNA therapeutics contract development and manufacturing (CDMO) market estimates and forecast, 2020-2030 (USD Million)
Fig. 56: Norway key country dynamics
Fig. 57: Norway mRNA therapeutics contract development and manufacturing (CDMO) market estimates and forecast, 2020-2030 (USD Million)
Fig. 58: Asia-Pacific mRNA therapeutics contract development and manufacturing (CDMO) market estimates and forecast, 2020-2030 (USD Million)
Fig. 59: Japan key country dynamics
Fig. 60: Japan mRNA therapeutics contract development and manufacturing (CDMO) market estimates and forecast, 2020-2030 (USD Million)
Fig. 61: China key country dynamics
Fig. 62: China mRNA therapeutics contract development and manufacturing (CDMO) market estimates and forecast, 2020-2030 (USD Million)
Fig. 63: India key country dynamics
Fig. 64: India mRNA therapeutics contract development and manufacturing (CDMO) market estimates and forecast, 2020-2030 (USD Million)
Fig. 65: Australia key country dynamics
Fig. 66: Australia mRNA therapeutics contract development and manufacturing (CDMO) market estimates and forecast, 2020-2030 (USD Million)
Fig. 67: Thailand key country dynamics
Fig. 68: Thailand mRNA therapeutics contract development and manufacturing (CDMO) market estimates and forecast, 2020-2030 (USD Million)
Fig. 69: South Korea key country dynamics
Fig. 70: South Korea mRNA therapeutics contract development and manufacturing (CDMO) market estimates and forecast, 2020-2030 (USD Million)
Fig. 71: Latin America mRNA therapeutics contract development and manufacturing (CDMO) market estimates and forecast, 2020-2030 (USD Million)
Fig. 72: Brazil key country dynamics
Fig. 73: Brazil mRNA therapeutics contract development and manufacturing (CDMO) market estimates and forecast, 2020-2030 (USD Million)
Fig. 74: Mexico key country dynamics
Fig. 75: Mexico mRNA therapeutics contract development and manufacturing (CDMO) market estimates and forecast, 2020-2030 (USD Million)
Fig. 76: Argentina key country dynamics
Fig. 77: Argentina mRNA therapeutics contract development and manufacturing (CDMO) market estimates and forecast, 2020-2030 (USD Million)
Fig. 78: MEA mRNA therapeutics contract development and manufacturing (CDMO) market estimates and forecast, 2020-2030 (USD Million)
Fig. 79: South Africa key country dynamics
Fig. 80: South Africa mRNA therapeutics contract development and manufacturing (CDMO) market estimates and forecast, 2020-2030 (USD Million)
Fig. 81: Saudi Arabia key country dynamics
Fig. 82: Saudi Arabia mRNA therapeutics contract development and manufacturing (CDMO) market estimates and forecast, 2020-2030 (USD Million)
Fig. 83: UAE key country dynamics
Fig. 84: UAE mRNA therapeutics contract development and manufacturing (CDMO) market estimates and forecast, 2020-2030 (USD Million)
Fig. 85: Kuwait key country dynamics
Fig. 86: Kuwait mRNA therapeutics contract development and manufacturing (CDMO) market estimates and forecast, 2020-2030 (USD Million)
Fig. 87: Key company categorization
Fig. 88: Company market positioning
Fig. 89: Market participant categorization
Fig. 90: Strategy framework